2m 2m 2m 2m 2m 2m 2m
Anika Therapeuti (ANIK)
NASDAQ
$15.60-$0.17 (-1.11%)
Price as of Jul 14, 2026 12:57 PM EDT- $209.8MMarket Cap
- 36.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Anika Therapeuti (ANIK)
$15.60-$0.17 (-1.11%)
ANIK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.77 | ||
Change | +$0.17 (+1.09%) | ||
Open | $15.68 | ||
High | $16.27 | ||
Low | $15.60 | ||
Previous Close | $15.60 | ||
Volume | 95,084 | ||
30-Day Average Volume | 81,607 | ||
1-Week Change | -1.62% | ||
1-Month Change | 7.13% | ||
1-Year Change | 36.77% | ||
3-Year Change | -37.86% | ||
5-Year Change | -62.57% | ||
Fundamentals | |||
Shares Outstanding | 13.3M | ||
Total Assets | $179.4M | ||
Market Cap | $209.8M | ||
Enterprise Value | $168.8M | ||
Period: QTR TTM FY | |||
Revenue | $29.6M | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$6.3M | ||
EBIT | -$4.8M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $72.6M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -49 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 2 | ||
P/E | -43 | ||
PEG | 0 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue